1 By bringing together experts in health education, behavior change, disease management, marketing, and program evaluation, Johnson & Johnson embarked on a large-scale, multiyear program to improve the health of its workers and, consequently, save the corporation money by reducing benefit expenditures and increasing worker productivity. To support this effort, the company invested several million dollars in program design, a significant portion of which was earmarked for external program evaluation. A series of evaluation studies performed during the 1980s and early 1990s showed that the company's health promotion and disease prevention program was associated with improved employee health, reduced inpatient health care expenditures, decreased employee absenteeism, and better employee attitudes. [1] [2] [3] [4] [5] [6] [7] These studies, published in peerreviewed journals, provided the impetus for broad application of the LIVE FOR LIFE program at all Johnson & Johnson companies, but with the expectation that the program would be subject to continuous quality improvement and ongoing rigorous evaluation.
Since its inception, the Johnson & Johnson health promotion and disease prevention program has undergone several transformations and adaptation to remain current and to respond to shifting business require- The newly formed Johnson & Johnson HWP placed greater emphasis than previously on health promotion and disease prevention. To encourage participation in its HWP, the corporation offered financial incentives to employees who completed an initial health risk assessment (HRA), including a biometric screening, and enrolled in a high-risk intervention program, if appropriate. The HRA and high-risk intervention programs were delivered through the Johnson & Johnson Health Care Systems. More generally, on-site program managers sought to permeate a prevention message across all major corporate benefit programs and to integrate functions so that they ran more efficiently.
The HWP concentrated on reducing individual behavioral and psychosocial risk factors before these were transformed into disease and disability. This approach was expected to be more cost-effective than prior programs because of the integration of services and the widespread involvement of health and wellness professionals, in concert with physicians and nurses. The HWP staff used the latest behaviorchange technologies directed at health habit improvements, early disease detection, and chronic disease management. 
Literature Review
Corporate-sponsored health management programs have come under increasing scrutiny in the past several years. 9 Although financial impact is generally of paramount concern to health and wellness program sponsors, there is often equal concern directed at establishing the program's effect on the health and wellbeing of participants (Johnson & Johnson. Customer advisory board survey results. Unpublished manuscript; 1989).
As a result of several recent program evaluation studies, there is growing evidence that worksite health promotion programs can achieve long-term health improvements in an employee population. 10 In a comprehensive literature review of close to 50 peer-reviewed studies spanning over 20 years, Heaney and Goetzel examined the effects of multicomponent worksite health promotion programs on employee health and productivity outcomes. 11 They concluded that worksite programs can be effective in changing employee health habits and reducing health risk, over extended time periods, if the programs are well designed, properly implemented, and appropriately evaluated. Their review also noted that the most effective programs offer individualized risk-reduction counseling and behavior change support within the context of a comprehensive health awareness-building corporate culture.
Most recently, two large-scale health impact studies conducted by Ozminkowski et al 12 and Gold et al 13 reported on the health outcomes from worksite-based health promotion programs. Using evaluation methods comparable with those described in this article, these researchers studied the effects of targeted health promotion interventions at Citibank 12 and across a group of employers. 13 At Citibank, the evaluators documented health risk improvements in 8 of 10 risk categories, examined over a 2-year period, for employees completing serial HRAs as part of a comprehensive health improvement program. Participants in a high-risk program improved their risk profile even more so than general program participants. Similarly, Gold et al found that highrisk program participants were significantly more likely to reduce their risks in six of seven risk categories targeted by the intervention program. These recent findings reinforce the conclusions of the Heaney and Goetzel review that targeted and intensive health management initiatives can be powerful agents in influencing population health at the workplace.
Description of the Johnson & Johnson HWP
The newly formulated Johnson & Johnson HWP focused on providing appropriate intervention services before, during, and after major healthrelated events (eg, illness, accidents, or injuries) occur. Pre-event management consisted of seven major activities: (1) HRA through the Johnson & Johnson Health Care System® Insight® Health Risk Appraisal sur-vey; (2) referral to high-risk intervention programs known as Pathways to Change® (PTC), based on HRA responses; (3) preventive health services and screening programs; (4) a focus on health education and self-responsibility; (5) health and safety education/training; (6) ergonomics assessments/job conditioning; and (7) workplace drug and alcohol awareness training.
At-event management consisted of 10 major activities: (1) emergency care, (2) limited non-occupational care, (3) occupational injuries/illness care, (4) medical case management with a much stronger emphasis on managed care and increased Health Maintenance Organization enrollment, (5) alternate/modified duty assessment if necessary, (6) medical surveillance and regulatory compliance, (7) health risk management programs, (8) critical incident response, (9) counseling and referrals through the employee assistance program, and (10) substance abuse management and referrals.
Post-event management programs focused on five major activities: (1) functional assessments to monitor progress, (2) a return-to-wellness program, (3) substance abuse-post rehabilitation program monitoring, (4) critical incident debriefing, and (5) alternate/modified duty monitoring. Because of integrated programming, some activities and functions were performed at both at-event and post-event periods.
Together, the pre-, at-, and postevent management activities spanned and coordinated corporate services among preventive medicine, worksite safety, medical treatment, disability, return-to-work, employee assistance, wellness, and medical benefit programs. The aim of the integrated approach was to maximize employee functioning and rapid return to work. As noted above, one major outcome expected from these efforts was improvement in employee health and well-being and a subsequent cost saving resulting from health improvement efforts.
To engage employees in the program, Johnson & Johnson offered a $500 medical benefit plan credit to program participants. Employees were invited to participate in a voluntary HRA, including biometric screening; if they accepted the invitation, they became eligible for the medical benefit credit. The screening determined if the employees were potentially at "high risk"; if so, they were then referred to the PTC "high risk" program.
To determine health risk, employees completed the Insight HRA, a four-page health assessment instrument covering the following risk areas: nutrition (fat and fiber intake), aerobic exercise, tobacco use (smoking, pipe, cigar, chewing tobacco), motor vehicle safety (seat belt use, drinking and driving), blood pressure (systolic and diastolic), blood cholesterol (total and high-density lipoprotein), body composition (high body weight/percent body fat), and diabetes risk. Referral to the PTC highrisk program was made if health risks were high in any of the following health risk areas: high serum cholesterol level (operationally defined as total cholesterol Ն240 mg/dL or high-density lipoprotein cholesterol Յ35 mg/dL), high blood pressure (values Ն140/90 mm Hg), or smoking (self-identified as smoking cigarettes). If employees refused participation in the high-risk program, they ran the risk of losing their $500 medical benefit credit. Participation in the program, not change in health risk status, was required to receive the medical benefit credit. Borderline-risk individuals received risk-specific mailings, whereas lowrisk employees received general health education mailings.
To assess program impact on employee health, the responses of participants who completed the Insight HRA assessment at least twice, with an appropriate time interval between assessments, were examined as part of this evaluation. We also examined differences in health risk changes for participants in the high-risk PTC program when compared with non-participants.
Methods

Sample
The Johnson & Johnson HWP Insight HRA was administered to approximately 43,000 US-based Johnson & Johnson employees (90% of those eligible to participate) between 1995, when the newly restructured program was first introduced, and 1999, the endpoint for the current investigation. Low-risk employees were subject to reassessment in 5-year intervals, whereas high-risk and borderline-risk employees were subject to more frequent reassessments. There were 4586 employees who participated in a second HRA assessment sooner than the standard 5-year interval between assessments, but with a minimum of 1 year between screenings. For those employees, the average time interval between the first and second HRA administration was 32.3 months, and the median time interval was 33 months (or about 2 3 ⁄4 years). 
Data Sources
Statistical Methods
Changes in the risk profile of employees as a result of participating in the HWP were assessed using a pretest/post-test cohort group research design. Data from all HWP participants who completed at least two HRA surveys were examined before and after their involvement in the program. McNemar chi-squared tests were used to determine whether the proportion of individuals at high risk differed over time, for each of the 13 risk categories examined. Program effectiveness was inferred if the proportion of participants at high risk was significantly lower at the second HRA administration when compared with baseline.
The impact of the high-risk PTC program was assessed by comparing trends in risks over time for PTC participants with those of non-participants, for employees with two HRA records. Specifically, differences in the proportion of employees at high risk were recorded over time, allowing trends to be discerned for the PTC and no-PTC groups. Differences in these trends were then assessed with a z-test. This test determined whether the change over time in the proportion of high-risk employees differed significantly for PTC participants versus non-participants. Table 2 provides descriptive statistics for HWP participants included in this study. Of the 4586 subjects, approximately half (n ϭ 2301) were enrolled in the high-risk PTC program. The average age of the sample was 42, and almost 45% were female. Most subjects (56%) were from the northeast census region, and most were enrolled in point of service (38%) or Health Maintenance Organization (28%) health plans. The mean number of risks recorded at the first HRA was 3.73.
Results
Sample Characteristics
Some differences in these characteristics were noted between PTC participants and non-participants. For example, Table 2 shows that PTC participants were less likely to be female (40%) compared with nonparticipants (51%). Some differences in location were noted as well, with slightly more participants (11%) in the north-central region (compared with 6% of non-participants) and fewer participants in the south (23%, vs 30% for non-participants). PTC participants were slightly older (43.53 years, vs 41.19 years for nonparticipants), but there were no differences in the average number of risks recorded at the first HRA (3.74 for participants vs 3.71 for non-participants).
Changes Over Time in Health Risk for all HWP Participants Table 3 shows changes in health risks over time for the entire study sample (n ϭ 4586). As shown, changes were statistically significant, and in the expected direction (with risks declining over time), for 8 of 13 risk categories examined. Significant risk reduction was found in the following categories, organized from greatest to least risk reduction over time: high serum cholesterol (66% to 43%), low dietary fiber intake (50% to 41%), poor exercise habits (46% to 35%), cigarette smoking (33% to 24%), high blood pressure (10% to 1%), lack of seat belt use (5% to 3%), drinking and driving (4% to 3%), and snuff use (1% to Ͻ1%). Four risk categories increased significantly (worsened) over time for the entire sample: high body weight (76% to 78%), risk for diabetes (49% to 52%), high dietary fat intake (22% to 25%), and cigar smoking (1% to 2%). Pipe smoking rates did not significantly change over time (Ͻ1% at both HRAs). Table 4 shows the proportion of employees at high risk at each HRA administration, for all 13 risk factors. Data are presented separately for PTC participants and non-participants. As shown, risks among participants improved in seven risk categories. These included risks related to low fiber intake, poor aerobic exercise habits, high total cholesterol, high blood pressure, cigarette smoking, chewing tobacco or snuff use, and failure to use seat belts. In all seven risk categories, the proportion of PTC participants at high risk declined significantly over time (P Ͻ 0.05, McNemar chi-squared test). A similar pattern was found for nonparticipants as well, with two exceptions. First, the decline in high blood pressure over time for non-participants was not statistically significant (P ϭ 0.7925, McNemar chi-squared test). Second, the risk of drinking and driving declined significantly over time among non-participants (P ϭ 0.0138, McNemar chi-squared test), but there was no significant difference in drinking and driving rates over time for PTC participants. For some categories, risks tended to increase over time. Among PTC participants, the proportion of employees with high fat intake increased significantly, although the increase was rather small (2.8%). Among non-participants, the proportion of employees at high risk increased significantly over time in three categories: high fat intake (an increase of 3.6% over time), high body weight (3.4%), and having multiple risk factors for diabetes (2.9% over time).
Changes Over Time in Health Risk for PTC Participants Versus Non-Participants
The last three columns of Table 4 present information that can be used to estimate the impact of the PTC program, without adjusting for differences between the demographic or other characteristics of PTC participants and non-participants. Table 4 suggests that PTC participants outperformed non-participants with regard to risk change in six categories. These included high fat intake, high body weight, poor aerobic exercise habits, having risk factors for diabetes, high cholesterol, and high blood pressure. In these six categories, the trends in risk over time were significantly more favorable for PTC participants than for non-participants (ztest for differences between PTC participant and non-participant trends in high risk over time, P Ͻ 0.05). On the other hand, trends in risk over time were significantly less favorable for PTC participants for five risk categories. These included low fiber intake, cigarette smoking, pipe smoking, failure to use seat belts, and drinking and driving. For risks related to cigar smoking and chewing tobacco or snuff use, trends in risk over time showed no significant differences between PTC participants and non-participants.
Discussion
Corporate health promotion and disease prevention programs are under constant pressure to produce outcomes that support the company's business objectives. Over several decades, Johnson & Johnson staff have devoted considerable time, resources, and expertise toward developing and documenting their programs' impact. When the company decided to restructure its health and wellness programs, senior management decided to again measure the newly configured program's effects on financial and health outcomes.
Previous research examined the new HWP impact on medical expenditures. This article describes the program's effect on employee health outcomes. By examining changes in the risk profile of 4586 employees who participated in two health risk appraisals over a 2 3 ⁄4 year period, we found improvement in 8 of 13 risk categories for the sample as a whole. Risk reductions were shown in tobacco use (cigarette smoking and snuff use), aerobic exercise, high blood pressure, high cholesterol, dietary fiber intake, seat belt use, and drinking and driving habits. On the other hand, the program was not successful in reducing risk factors often associated with increased age: high body weight, risk for diabetes, high fat diet, and cigar and pipe smoking.
The analysis also found that participation in the PTC high-risk program resulted in better health outcomes for six risk factors, and worse outcomes for five other risk factors. As noted earlier, the PTC program was particularly targeted toward employees with high blood pressure and high cholesterol and toward those who smoked. Participation seems to have had a significant impact on those with hypertension and hypercholesterolemia, and a significantly negative impact on smoking rates. In summary, it seems that both participants and non-participants were motivated to improve their behaviors and reduce their risks and that participation in the PTC program may have provided a slightly greater impetus for change. Why are these findings important? First, they highlight the positive impact that large-scale corporate health promotion efforts can achieve on employee health. When positive health improvement results are coupled with results showing financial savings from medical benefit programs, these findings are very compelling and reassuring to program sponsors. Perhaps even more important is a demonstration of a large corporation's ability to efficiently implement a complex, large-scale, and far-reaching population health management program that achieves very high participation rates (ie, 90%). Achieving such high participation rates in a work setting is very rare, but as shown here, the positive impact on health and medical costs can be significant.
Health promotion program planners have always asserted that to be successful their programs must achieve high participation rates and be effective in modifying participants' behaviors, thus lowering their population's health risks. It is further assumed that if these outcomes are achieved, cost savings will follow. This study, one in a series of evaluations directed at Johnson & Johnson's health promotion and disease prevention programs, seems to support assumptions about corporate initiatives aimed at improving the risk profile of the workforce. As reported earlier, 8 the Johnson & Johnson HWP achieved significant cost savings as well. Taken together, these studies underscore the logic that well-designed, well-implemented, and well-evaluated health promotion and disease prevention programs achieve positive and documented results. Achievement of these outcomes should help reinforce the corporate objectives of attracting and retaining a healthy and productive workforce.
Limitations
The most significant limitation to this research is the use of a pre-test/ post-test research design, without a randomized control group. Because of the very high participation rates in the HWP, no suitable comparison group could be found. Consequently, because neither a randomized control nor a non-randomized comparison group was available to examine the behaviors and risk profile of nonparticipants over time, it cannot be established with confidence that the behavior changes and risk-reduction profile of program participants were a direct result of the program. Other factors may have contributed to risk changes over time, such as educational programs offered by health plans, or a general increase in awareness about health issues promulgated by the popular press. Ideally, information would be collected for all employees at multiple points in time, and surveys would be conducted to help differentiate between competing reasons for risk change when a randomized trial or well-designed quasiexperimental study are not feasible.
Other limitations include the inevitable problems related to self-report. Employees may have offered socially desirable responses to their HRA questions to avoid having to participate in the PTC program and to receive the $500 medical benefit credit. This might be particularly problematic for cigarette smoking, as evidenced by the very low percentage of smokers in the PTC group (about 10%, Table 4 ) and the very high percentage of smokers among non-participants in the PTC program (about 61%, Table 4 ). Self-reported risks for other problems seemed within ranges reported in other studies, however. 12, 14 Finally, the PTC program was not implemented as part of a randomized trial, and no adjustments were made for differences in the demographics or other characteristics of PTC participants versus non-participants when the PTC impact was estimated. We decided against adjustments for these differences because the PTC program was developed mainly to address risks related to cholesterol, high blood pressure, and smoking, not all 13 of the risk factors examined. Thus, comments on the impact of PTC with regard to many risks would have to be viewed with caution even if adjustments had been made, and a reliance on adjusted differences might therefore produce a false sense of security.
Conclusion
This study of Johnson & Johnson's newly restructured HWP follows a long tradition within the corporation of introducing innovative health improvement initiatives that engage a large segment of the employee population and are supported by a culture that encourages a healthy lifestyle. The evaluation of the program complements a growing body of literature that supports the notion of corporate investment in the health and well-being of employees. As health care costs continue to rise, partly as a result of an aging workforce and partly because of increased stressors in employees' lives, corporate decision-makers will seek innovative programs that promote health and reduce costs. Senior executives would be wise to consider the mounting evidence accumulated here and in other studies conducted over the past 20 years that supports corporate investment in worker health. As illustrated here, such investment may result in better risk profiles. As noted elsewhere, a well-designed health promotion and disease prevention program may reduce benefit costs and improve worker productivity. 10 
